Dr. Abdussalam Shredi, MD

Dr. Shredi practices at Ephraim McDowell Regional Medical Center in Danville, Kentucky, part of Ephraim McDowell Health.

Dr. Shredi's NPI, 1649727827, was assigned on September 6, 2016. Dr. Shredi graduated from University of Tripoli School of Medicine in 2009. Dr. Shredi holds Kentucky license 53066.

Dr. Shredi's primary practice is Ephraim McDowell Regional Medical Center, at 217 South Third Street, Danville, KY 40422 in Boyle County. The practice phone is (859) 239-1000.

Dr. Shredi's primary practice is Ephraim McDowell Regional Medical Center in Danville, Kentucky, part of Ephraim McDowell Health. Dr. Shredi is also affiliated with Select Specialty Hospital - Central Kentucky. The medical group on file is 24 On Physicians, PC. Dmand AI also links Dr. Shredi to 5 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shredi practices, 10 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Shredi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Shredi is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Shredi's licenses on file in 2 states: Kentucky and Texas.

Dmand AI lists acute diabetes, acute respiratory failure, anemia, atrial fibrillation and flutter, bile duct problems, cardiac arrhythmia, cellulitis and congestive heart failure among the conditions Dr. Shredi treats.

CMS data shows 857 Medicare services from Dr. Shredi across 5 procedure codes in 2024, for 286 Medicare patients. Medicare paid $67,016 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 286 Medicare patients who saw Dr. Shredi in 2024. The largest group is 75 to 84, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.27, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shredi's median patient age at 74, with 59% women.

In 2024, Dr. Shredi wrote 466 Medicare Part D claims for 208 patients. 88% of them were for generic drugs. CMS names the drug for 214 of them, across 12 drugs with 11 or more claims each, at $7,684 in total drug cost. In 2023, CMS named 204 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Shredi for performance year 2024, reported as part of a group. Dr. Shredi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 3 general payments to Dr. Shredi from 2 drug and device companies from 2017 to 2019. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $26.

Dmand AI lists 1 award for Dr. Shredi, most recently Research Day Award in 2019.

Dr. Shredi graduated from University of Tripoli School of Medicine in 2009. Dr. Shredi is a member of ACP.

Dr. Shredi is in network with 19 carriers, including Blue Cross Blue Shield of Michigan, United Healthcare and Aetna. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.